
ActX
Focused on making patient genomic information that are useful in everyday medical practice.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | $6.0m | Late VC |
Total Funding | 000k |
Related Content
ActX operates at the intersection of healthcare and genomics, providing EHR-integrated genomic decision support to physicians and healthcare providers. The company focuses on making personalized and precision medicine practical by offering actionable genetic information that can be used to tailor medical care to individual patients. ActX serves a diverse client base, including physicians, healthcare systems, and EHR partners, helping them integrate genomic data into their practice to improve patient outcomes. The business model revolves around subscription-based services and partnerships with healthcare providers and EHR systems, generating revenue through service fees and licensing agreements. ActX's market is primarily within the healthcare and medical technology sectors, targeting professionals who aim to leverage genomic data for better clinical decision-making.
Keywords: Genomic decision support, EHR integration, personalized medicine, precision medicine, healthcare providers, genetic testing, actionable information, patient care, medical technology, subscription services.